small molecule

SOTALOL HYDROCHLORIDE

Loss of exclusivityAugust 2039latest FDA-listed patent expiry

CompanyAltaThera Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand name	SOTALOL HYDROCHLORIDE
Active ingredient	SOTALOL HYDROCHLORIDE
Strength	150MG/10ML (15MG/ML)
Dosage form	SOLUTION
Route	INTRAVENOUS
Modality	Small molecule
FDA approval	July 2009
Marketing status	RX

Listed patents

Patent	Expires	Type
11583216	August 2039	use U-3549
10799138	April 2039	use U-3125
12569183	April 2039	use U-4456
12390431	August 2038	use U-2769
10512620	August 2038	use U-3547
11696902	August 2038	use U-2769
12403109	August 2028	use U-2769

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.